Rice University scientists create electrical protein switches triggered by chemicals
Scientists at Rice University have developed synthetic protein switches to control the flow of electrons.
The proof-of-concept, metal-containing proteins made in the Rice lab of synthetic biologist Joff Silberg are expressed within cells upon the introduction of one chemical and are functionally activated by another chemical. If the proteins have been placed in the cell, they can simply be turned on and off.
“This is not a metaphor for a switch, it is a literal electrical switch built from a protein,” Silberg said.
The proteins could facilitate next-generation bioelectronics, including complete biological circuits within cells that mimic their electronic counterparts. The possible applications include living sensors, electronically controlled metabolic pathways for chemical synthesis and active pills that sense their environment and release drugs only when needed.
The work appears in Nature Chemical Biology.
“Biology is really good at sensing molecules,” said Silberg, a professor of biosciences and bioengineering. “That’s an amazing thing. Think about how complex the cell is, and how proteins evolve that can respond to a single prompt in a sea of information. We want to leverage that exquisite ability to build more elaborate biomolecules and use these to develop useful synthetic biology technologies.”
The Rice team takes advantage of those innate abilities. “Natural proteins that move electrons more or less act as wires that are always there,” said Systems, Synthetic, and Physical Biology graduate student and lead author Josh Atkinson. “If we can turn these pathways on and off, we can make cells operate more efficiently.”
Rice’s metalloprotein switches – so called for their iron content – are quick, Silberg said. Nature typically controls electron flow by using genetic mechanisms to control the production of the protein “wires.”
“It’s all transcriptional,” he said. “Even in a fast-growing E. coli bacteria, it takes many minutes. By contrast, protein switches function on a time scale of seconds.”
To make the switch – which they use in a synthetic electron transfer pathway – the researchers needed a stable protein that could be reliably split along its peptide backbone to allow for the insertion of protein fragments that complete or break the circuit. They based the switch on ferredoxin, a common iron-sulfur protein that mediates electron transfer in all the domains of life.
Atkinson built switches embedded in E. coli that can be turned on in the presence (or off in the absence) of 4-hydroxytamoxifen, an estrogen receptor modulator used to fight breast and other cancers, or by bisphenol A (BPA), a synthetic chemical used in plastics.
Their E. coli bacterium is a mutant strain that is programmed to only grow in a sulfate medium when all of the components of the ferredoxin electron transport chain – including electron donor and acceptor proteins – are expressed. That way, the bacteria could only grow if the switches turn on and transfer electrons as planned.
Silberg said the discovery should lead to custom-designed switches for many applications, including contact with external electronic devices. “It’s why we’ve been so gung-ho about this idea of bioelectronics, a whole field that’s emerging as synthetic biology gets more control over the design,” he said. “Once you can standardize this, there are all kinds of things we can build with cells.”
That could include smart pills that release medications only on demand, or gut biome detectors that report on conditions. Or perhaps electrical circuits contained entirely within cells.
“We can already map a lot of what electrical engineers do with capacitors and resistors onto metabolism, but until now, there have been no switches,” Silberg said.
He suggested multiple switches could also turn a cell into a biological processor. “Then we could see digital parallel processing in the cell,” he said. “It changes the way we look at biology.”
Learn more: Switch-in-a-cell electrifies life
The Latest on: Bioelectronics
via Google News
The Latest on: Bioelectronics
- New 3D interconnection technology for future wearable bioelectronicson August 15, 2019 at 5:39 am
Scientists developed stretchable metal composites and 3D printed them on soft substrates at room temperature. By enabling ever-slimmer 3D interconnects, this study can help to revolutionize the ...
- Hi-tech patch could end painful periods for millions of womenon August 13, 2019 at 2:13 am
The patch's US manufacturer, BioElectronics, claims this triggers the cells to pump out excess fluid, reduce bloating, pain and swelling. It's been shown to slash pain levels by more than 70 per cent ...
- BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Applicationon August 9, 2019 at 11:10 am
Before it's here, it's on the Bloomberg Terminal.
- Theranica Bioelectronics Hopes to Take Migraine Device Globalon August 6, 2019 at 6:44 pm
While Nerivio Migra has been approved by the FDA, the company is aiming to take the device global to treat patients in other territories. Privately owned Theranica Bioelectronics is aiming to ...
- Conformable bioelectronic interfaces: Mapping the road aheadon July 31, 2019 at 11:33 am
In parallel, bioelectronics research in academic laboratories is fueling innovation in materials, device integration, and therapeutic applications to answer the increasing demand for medical devices ...
- Bioelectronics and Biosensors Market to Witness Considerable Upsurge during 2019-2026on July 19, 2019 at 3:50 am
The bioelectronics and biosensors market size was valued at USD 17.5 billion in 2016 and is projected to reach to USD 41.9 billion by 2026 at a CAGR of 9.2%. This is a comprehensive global report ...
- The Stock Day Podcast Hosts BioElectronics' to Discuss Its New Technology To Mitigate Opioid Useon July 10, 2019 at 5:03 am
PHOENIX, AZ / ACCESSWIRE / July 10, 2019 / The Stock Day Podcast welcomed BioElectronics Corporation (BIEL) (“the Company”), a leader in non-invasive electroceuticals and the maker of an industry ...
- BioElectronics Announces Publication of Study Verifying the Effectiveness of Its ActiPatch Medical Device on Chronic Painon June 3, 2019 at 6:33 am
FREDERICK, MD, June 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK:BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, is pleased to ...
- BioElectronics Announces Withdrawal and Planned Resubmission of 510(k) for General Musculoskeletal Painon May 21, 2019 at 5:00 pm
FREDERICK, MD, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL) www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today ...
via Bing News